TO · WLLW.TO
Willow Biosciences Inc.
- Sector
- Healthcare · Drug Manufacturers - Specialty & Generic
- Headquarters
- Calgary, AB T2R 0Y6
- Website
- willowbio.com
Price at previous close
$0.04
Market cap 5.15M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | $0.00 | $38.03 | |||
| 2020 | $1.50 | $38.69 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.35 | $171.97 | $0.03 | $0.00 | $0.00 |
| 2022 | $0.09 | $74.64 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.10 | $30.56 | $0.05 | $0.00 | $0.00 |
| 2024 |
About Willow Biosciences Inc.
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.
- CEO
- Travis Doupe
- Employees
- 19
- Beta
- 4.65
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($0.02 ÷ $0.04) − 1 = -42.86% (DCF, example).